Unknown

Dataset Information

0

Acquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma.

ABSTRACT:

SUBMITTER: Portuguese AJ 

PROVIDER: S-EPMC10698540 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
| S-EPMC12451653 | biostudies-literature
Unknown Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells.
| S-EPMC10743602 | biostudies-literature
Unknown Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma.
| S-EPMC11302451 | biostudies-literature
Unknown Novel BCMA-OR-CD38 tandem-dual chimeric antigen receptor T cells robustly control multiple myeloma.
| S-EPMC8381848 | biostudies-literature
Unknown Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple Myeloma.
| S-EPMC8447280 | biostudies-literature
Unknown Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma.
| S-EPMC10504087 | biostudies-literature
Unknown CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.
| S-EPMC6205194 | biostudies-literature
Unknown Anti CD38 monoclonal antibodies for multiple myeloma treatment.
| S-EPMC9225612 | biostudies-literature
Unknown CD38-Directed Therapies for Management of Multiple Myeloma.
| S-EPMC8254545 | biostudies-literature
Unknown The Anti-CD38 Antibody Therapy in Multiple Myeloma.
| S-EPMC6952883 | biostudies-literature